Vaccine company Moderna has signed a deal to set up operations in Shanghai to develop and make mRNA products specifically for the China market. Moderna’s CEO, Stéphane Bancel, was in Shanghai this week to set up the new venture. While Moderna confirmed an agreement has been signed, it did not disclose a monetary value, though multiple outlets said the firm would invest up to $1 billion to establish a China presence. Moderna rocketed into the big league with the success…